A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2004
11/11/2004	WO2003097356A9 Camptothecin derivatives and polymeric conjugates thereof
11/11/2004	WO2003077850A3 N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7- carboxamides useful as hiv integrase inhibitors
11/11/2004	WO2003070747A3 Insulin and igf-1 receptor agonists and antagonists
11/11/2004	WO2003059264A9 Methods for the induction of professional and cytokine-producing regulatory cells
11/11/2004	WO2003050085A8 CRYSTALLINE [R-(R,R)]-2-(4-FLUOROPHENYL)-β,δ-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-HEPTANOIC ACID CALCIUM SALT (2:1)
11/11/2004	WO2000063175A3 Novel process
11/11/2004	US20040225132 Carvedilol
11/11/2004	US20040225015 Carba-sugar amine derivative and glycolipid metabolic disorder treating agent containing the same as active ingredient
11/11/2004	US20040225013 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents
11/11/2004	US20040225011 E.g., ajulemic acid; used for decreasing cell proliferation
11/11/2004	US20040225008 such as N-(4-{[methyl-(2-propynyl)amino]methyl}phenyl)-2-thiophenecarboximidamine; for inhibiting nitrogen oxide synthases and/or monoamine oxidases
11/11/2004	US20040225006 Useful in treatment and prophylaxis of conditions mediated by s-CD23 or tumor necrosis factor; autoimmune disease, inflammation, allergy
11/11/2004	US20040224996 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/11/2004	US20040224977 Racemic mixtures for treatment of diseases with alpha 7nicotinic acetyl chloline administering
11/11/2004	US20040224976 Azabicyclic compounds for the treatment of disease
11/11/2004	US20040224969 Salts of substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid compounds
11/11/2004	US20040224966 Enzyme inhibitors as drugs for cardiovascular disorders, aids, alzheimers disease or urogenital disorders
11/11/2004	US20040224965 Treatment of cardiovascular disorders, thrombosis, surgery and nhe inhibitors
11/11/2004	US20040224959 such as N-benzyl-3-[4-(3,3-diphenyl-1-propyl)piperazin-1-yl]-N-methylbenzamide; for inhibition of secretion of apolipoprotein B lipoprotein from the liver; for treatment of hyperlipidemia, pancreatitis
11/11/2004	US20040224958 Pyridopyrimidinone derivatives for treatment of neurodegenerative disease
11/11/2004	US20040224956 Crystal of 6-[4-(4-pyridylamino)phenyl]-4,5-dihydro-3(2h)-pyridazinone hydrochloride trihydrate
11/11/2004	US20040224955 Viral polymerase inhibitors
11/11/2004	US20040224954 Substituted 1H-quinoxalin-2-one compounds and substituted 4-aryl- and 4-heteroarylcyclohexane compounds
11/11/2004	US20040224945 Novel substituted pyrazole derivatives
11/11/2004	US20040224941 Carboxylic acid derivatives and drugs containing the same as the active ingredient
11/11/2004	US20040224925 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
11/11/2004	US20040224924 Programming a specific course and rate for a parent drug compound's metabolism that leads to an inactive or weakly active and non-toxic metabolite when the parent drug compound is administered, comprising modifying the parent drug compound by forming one or more of a predetermined chemical arrangement
11/11/2004	US20040224919 Restoring cancer-suppressing functions to neoplastic cells through DNA hypomethylation
11/11/2004	US20040224911 Transporters and ion channels
11/11/2004	US20040224904 Carbohydrate scaffold, carrying two side chains, which form a macrocyclic ring that may be unsaturated and contains ether, amide, ester and/or carbamate groups; for therapy of bacterial, fungal, viral or protozoal infections or tumors
11/11/2004	US20040224898 inducing lypolysis using a nucleic acid expression vector coding for an insect adipokinetic hormone polypeptide; cyclization and amidation; dietetics; drug screening
11/11/2004	US20040224885 Methods of treating hypertension and compositions for use therein
11/11/2004	US20040224424 Nucleotide sequences comprising allelic variant of cytochrome p450 for use in diagnosis and treatment of cell proliferative, nervous system and cardiovascular disorders; pharmacodynamic profiles and drug screening
11/11/2004	US20040224386 Protein tyrosine kinases
11/11/2004	US20040224378 Methods for using ADAMTS-12, an integrin and metalloprotease with thrombspondin motifs
11/11/2004	US20040224314 G-protein coupled receptors
11/11/2004	US20040224033 Side effect-relieving agents and/or hypoglycemic effect enhancers for thiazolidine compounds
11/11/2004	US20040224027 useful for tissue regeneration, particularly when used with orthopedic implants and drug delivery
11/11/2004	US20040224026 Collagen/polysaccharide bilayer matrix
11/11/2004	US20040224023 Compositions and methods for treating or preventing diseases of body passageways
11/11/2004	US20040224022 Collagen/polysaccharide bilayer matrix
11/11/2004	US20040223968 inhibiting a condition characterized by monocytic infiltrates such as atherosclerosis by administering an MCP-1 receptor antagonist that binds to an MCP-1 receptor polypeptide, especially a humanized or monoclonal antibody.
11/11/2004	US20040223958 Glutathione reductase for therapy and prophylaxis of AIDS
11/11/2004	CA2524245A1 The use of azetidinecarboxamide derivatives in therapy
11/11/2004	CA2524175A1 Sugar intake-ability enhancer
11/11/2004	CA2523912A1 Human antihuman interleukin-18 antibody, fragment thereof and method of using the same
11/11/2004	CA2523539A1 Production of high mannose proteins in plant culture
11/11/2004	CA2518947A1 Antiallergic composition
11/10/2004	EP1475382A1 Compounds as semaphorin inhibitors
11/10/2004	EP1475377A1 Derivatives of indole and their use as phosphodiesterase 4 inhibitors
11/10/2004	EP1475376A1 Hair composition containing a pyrimidine-n-oxide derivative and its use to stimulate keratinic fiberes growth and/or preventing their loss
11/10/2004	EP1475368A1 N-carbamoyl nitrogen-containing fused ring compounds and drugs containing these compounds as the active ingredient
11/10/2004	EP1475102A1 Remedy for hypertension
11/10/2004	EP1475095A1 Percutaneous preparations
11/10/2004	EP1475093A1 Micronized Zolpidem hemitartrate
11/10/2004	EP1475090A1 Drugs for mitochondrial diseases
11/10/2004	EP1475086A2 Sibutramine metabolites
11/10/2004	EP1475083A1 Method for producing an active ingredient concentrate, and active ingredient concentrate
11/10/2004	EP1474687A2 Marks as modifiers of the p53 pathway and methods of use
11/10/2004	EP1474445A1 Glycoisoforms of adiponectin and uses thereof
11/10/2004	EP1474441A1 Tripeptides having a hydroxyproline ether of a substituted quinoline for the inhibition of ns3 (hepatitis c)
11/10/2004	EP1474438A2 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
11/10/2004	EP1474431A2 Macrolide antibacterial compounds
11/10/2004	EP1474425A1 Deazapurines and uses thereof
11/10/2004	EP1474424A1 Tricyclic 2-pyrimidone compounds useful as hiv reverse transcriptase inhibitors
11/10/2004	EP1474421A1 Imidazole 4-carboxamide compounds with adenosine deaminase inhibiting activity
11/10/2004	EP1474419A1 Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes
11/10/2004	EP1474415A1 1-phenyl-2-heteroaryl-substituted benzimidazole derivatives, the use thereof for producing drugs used in the treatment of immunological diseases
11/10/2004	EP1474408A1 N-phenyl-2-pyrimidine-amine derivatives
11/10/2004	EP1474405A2 Process for the preparation of 4-hetero-substituted phenylalanine derivatives
11/10/2004	EP1474403A2 Urea derivatives and their use as vanilloid receptor antagonists
11/10/2004	EP1474402A1 Salts of valsartan
11/10/2004	EP1474401A2 Novel aryl- and heteroarylpiperazines
11/10/2004	EP1474400A1 2-[5-(5-carbamimidoyl-1h-heteroaryl)] -6-hydroxybiphenyl-3-yl derivatives as factor viia inhibitors
11/10/2004	EP1474399A1 Benzenesulfonamide derivatives as antipsychotic agents
11/10/2004	EP1474397A1 Therapeutic acridone and acridine compounds
11/10/2004	EP1474396A2 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
11/10/2004	EP1474395A1 Nicotinamide derivates useful as p38 inhibitors
11/10/2004	EP1474394A1 Pyridineamido derivatives as inhibitors of monoamine oxidase (mao-b)
11/10/2004	EP1474393A1 Aryl ureas as kinase inhibitors
11/10/2004	EP1474392A1 Polymorphic form xvi of fexofenadine hydrochloride
11/10/2004	EP1474387A2 Derivatives of alpha-phenylthiocarboxylic and alpha-phenyloxy-carboxylic acids useful for the treatment of diseases responding to ppar alpha activation
11/10/2004	EP1474385A1 Urea linker derivatives for use as ppar modulators
11/10/2004	EP1474380A2 4-dedimethylamino tetracycline compounds
11/10/2004	EP1474168A1 7s immunoglobulin for treatment of choroidal neovascularisation
11/10/2004	EP1474158A2 Prevention and treatment of oxidative stress disorders by glutathione and phase ii detoxification enzymes
11/10/2004	EP1474151A2 Methods of treatment of chronic immune disease
11/10/2004	EP1474148A1 Treatment of neuroblastoma
11/10/2004	EP1474147A1 Pyrimidine-based compounds useful as gsk-3 inhibitors
11/10/2004	EP1474146A1 Phenylpyrimidine amines as ige inhibitors
11/10/2004	EP1474145A1 Quinoline derivatives as npy antagonists
11/10/2004	EP1474144A1 Controlled release pharmaceutical dosage forms of a cholesteryl ester transfer protein inhibitor
11/10/2004	EP1474141A1 5-ht2b receptor antagonists
11/10/2004	EP1474140A1 2-oxazolamines and their use as 5-ht2b receptor antagonists
11/10/2004	EP1474139A2 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
11/10/2004	EP1474137A1 Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases
11/10/2004	EP1474134A1 Combination preparation of the sodium-hydrogen exchange inhibitor cariporide with ace inhibitors for preventing heart failure and other age-related dysfunctions of organs, age-related diseases and for prolonging lifespan
11/10/2004	EP1474129A1 Use of genistein in the manufacture of a medicament for the treatment of osteoporosis and obesity, and compositions containing genistein in combination with vitamin d and k
11/10/2004	EP1474127A1 Biphenyl derivatives and their use as antiandrogenic agents
11/10/2004	EP1474122A2 Compounds for blocking androgen receptors

1 ... 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 ... 1564